BRIEF published on 09/16/2024 at 15:05, 2 months 4 days ago CORSAIR to Acquire Fanatec Sim Racing Product Line Acquisition Investment Corsair Fanatec Sim Racing
PRESS RELEASE published on 09/16/2024 at 15:00, 2 months 4 days ago CORSAIR is set to acquire Fanatec Sim Racing CORSAIR to acquire Fanatec Sim Racing product line from Endor AG, enhancing Sim Racing experience with high-quality hardware. Transaction expected to close soon Acquisition Corsair Sim Racing Fanatec Sim Racing High-quality Hardware
BRIEF published on 09/13/2024 at 21:27, 2 months 7 days ago Endor AG's Business Acquired by CORSAIR Amid Insolvency Acquisition Liquidation Insolvency Corsair Employment Contracts
PRESS RELEASE published on 09/13/2024 at 21:22, 2 months 7 days ago EQS-Adhoc: Endor AG: Endor AG's business is taken over by CORSAIR CORSAIR acquires Endor AG's business operations as Endor AG faces insolvency proceedings and liquidation. Shareholders to expect no payments Acquisition Liquidation Endor AG Insolvency Corsair
BRIEF published on 08/27/2024 at 20:34, 2 months 24 days ago Endor AG: Extraordinary General Meeting on September 3, 2024 Cancelled Investor Relations Endor AG Cancellation Extraordinary General Meeting Court Suspension
PRESS RELEASE published on 08/27/2024 at 20:29, 2 months 24 days ago Endor AG: Extraordinary General Meeting on September 3, 2024 Cancelled Endor AG cancels extraordinary general meeting scheduled for September 3, 2024, following court decision. Details in press release Endor AG Press Release Cancellation Extraordinary General Meeting Court Decision
BRIEF published on 08/16/2024 at 14:05, 3 months 4 days ago Goetzpartners Corporate Finance Launches Sales Process for Endor AG Endor AG Insolvency Investor Interest Corporate Sale Goetzpartners
PRESS RELEASE published on 08/16/2024 at 14:00, 3 months 4 days ago goetzpartners Corporate Finance launches sales process for Endor AG goetzpartners Corporate Finance launches sales process for Endor AG. Landshut-based SimRacing specialist seeks buyer after insolvency filing Sales Process Endor AG Insolvency Goetzpartners Corporate Finance SimRacing
BRIEF published on 07/30/2024 at 23:05, 3 months 21 days ago Endor AG Files for Insolvency Endor AG Insolvency Reorganisation Debt StaRUG
PRESS RELEASE published on 07/30/2024 at 23:00, 3 months 21 days ago Endor AG files for insolvency Endor AG files for insolvency, business operations to continue without restrictions. Open-ended process to take over the company initiated. Foreign companies unaffected Endor AG Business Operations Insolvency Reorganisation Investor
Published on 11/21/2024 at 13:30, 25 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 25 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 55 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 55 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 55 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 20 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 40 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 57 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 35 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 10 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 10 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
